BioSpace News Archive

Biotech Bay

BillionToOne Announces Clinical Outcomes Data for UNITY Fetal Risk™ Screen, Demonstrating Exceptional Accuracy in General Pregnancy Population

BillionToOne announced that a peer-reviewed research study of the UNITY Fetal Risk Screen has been published in Prenatal Diagnosis.

October 30, 2023
·
3 min read
NeuroTrigger Received FDA 510(k) for that its non-invasive muscle stimulation system (NTB)

NeuroTrigger is pleased to announce that its non-invasive muscle stimulation system (NTB) has been granted 510(k) clearance by the US Food & Drug Administration (FDA) for the prevention or retardation of disuse atrophy and muscle re-education to maintain or increase range of motion.

October 30, 2023
·
1 min read
Dyadic to Present at Industry Events in November

Dyadic International, Inc. today announced that its management will be participating and presenting at the following industry events during the month of November.

October 30, 2023
·
4 min read
Business

Cardio Flow Announces Completion of First Commercial Cases of Innovative FreedomFlow Orbital Atherectomy Platform—and Appointment of Chief Operating Officer

Cardio Flow, Inc. is pleased to announce the successful completion of its first commercial cases for its FreedomFlow® Orbital Atherectomy Platform following FDA clearance in late September.

October 30, 2023
·
4 min read
Pharm Country

Schrödinger to Host Pipeline Day on December 14, 2023

Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that the company will host its Pipeline Day in New York City on Thursday, December 14, 2023, beginning at 10:00 a.m. ET.

October 30, 2023
·
2 min read
Business

Tris Pharma Partners with Perigon Pharmacy 360 to Enhance Access to DYANAVEL® XR Tablets for the Treatment of Attention Deficit Hyperactivity Disorder

Tris Pharma, Inc. today announced a new partnership with Perigon Pharmacy 360, a full-service, specialty digital pharmacy, to enhance accessibility, affordability and adherence for patients treating symptoms of ADHD with Tris’ DYANAVEL® XR (amphetamine) extended-release tablets.

October 30, 2023
·
9 min read
Business

Magdalena Biosciences, a Joint Venture between Jaguar Health and Filament Health, Receives Second Tranche of Funding from One Small Planet

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Magdalena Biosciences, Inc. (Magdalena), the joint venture recently formed by Jaguar and Filament Health Corp. has received the second tranche of funding from One Small Planet.

October 30, 2023
·
7 min read
Biotech Beach

NEURELIS TO PARTICIPATE IN 11th ANNUAL SOFIE’S JOURNEY EPILEPSY AWARENESS DAY AND EDUCATION EXPO AT DISNEYLAND® RESORT

Neurelis Inc., is proud to take part in the 11th Annual Sofie’s Journey Epilepsy Awareness Day and Education Expo at Disneyland Resort (EADDL), the largest, worldwide epilepsy community gathering of the year.

October 30, 2023
·
9 min read
Business

Rapport Therapeutics Appoints Chief Financial Officer

Rapport Therapeutics, Inc. today announced the appointment of industry veteran Troy Ignelzi as Chief Financial Officer, effective November 1, 2023.

October 30, 2023
·
3 min read
Salignostics’ Salistick, the World’s First Saliva-Based Pregnancy Test, Recognized by TIME as One of the Best Inventions of 2023

Salignostics, an Israeli saliva research and product development start-up, is proud to announce its groundbreaking pregnancy test, Salistick, has been selected as one of TIME magazine’s Best Inventions of 2023.

October 30, 2023
·
3 min read